设为首页 加入收藏

TOP

NEUTROGENA CLINICAL LIFTING WRINKLE TREATMENT SYSTEM(avobenz
2014-03-02 19:13:01 来源: 作者: 【 】 浏览:430次 评论:0

Warning

For external use only. Avoid contact with eyes. If contact occurs, flush thoroughly with water. Discontinue use if irritation or rash appear.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Active Ingredients

Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 5%, Oxybenzone 3%

Inactive Ingredients

Water
Butylene Glycol
C12-15 Alkyl Benzoate
Tetrahydroxypropyl Ethylenediamine
Silica
Cetearyl Alcohol
Cyclopentasiloxane
Dimethicone
Steareth-2
Glyceryl Stearate
Steareth-21
Aluminum Starch Octenylsuccinate
Cetearyl Glucoside
C13-14 Isoparaffin
Dimethicone/Vinyl Dimethicone Crosspolymer
Arachidyl Alcohol
PEG-100 Stearate
Disodium EDTA
Polyacrylamide
Behenyl Alcohol
Acrylates/C10-30 Alkyl Acrylate Crosspolymer
Propylparaben
Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate
Arachidyl Glucoside
Laureth-7
Citric Acid
Benzyl Alcohol
Phenoxyethanol
Methylparaben
Ethylparaben
Fragrance

Questions

1-800-582-4048 or www.neutrogena.com

PRINCIPAL DISPLAY PANEL - Kit Carton

NEW

Neutrogena
clinical

lifting wrinkle treatment system

visibly smoothes wrinkles and firms
for a resilient, youthful look

STARTER SYSTEM
SPF 30 EYE

helloplex®

with
ion2complex

gel serum+ spf 30 activating+
cream
eye activating
cream

GEL SERUM 0.5 FL OZ (14mL) • SPF 30 ACTIVATING CREAM 0.33 FL OZ (10mL)
EYE ACTIVATING CREAM 0.17 FL OZ (5mL)

PRINCIPAL DISPLAY PANEL - Kit Carton

 

 


NEUTROGENA CLINICAL LIFTING WRINKLE TREATMENT SYSTEM
avobenzone, homosalate, octisalate, octocrylene, and oxybenzone cream
Product Information
Product Type HUMAN OTC DRUG NDC Product Code (Source) 10812-130
Route of Administration TOPICAL DEA Schedule  
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Avobenzone(Avobenzone) Avobenzone 30mg in1mL
Homosalate(Homosalate) Homosalate 120mg in1mL
Octisalate(Octisalate) Octisalate 50mg in1mL
Octocrylene(Octocrylene) Octocrylene 50mg in1mL
Oxybenzone(Oxybenzone) Oxybenzone 30mg in1mL
Inactive Ingredients
Ingredient Name Strength
No Inactive Ingredients Found
Product Characteristics
Color   Score  
Shape   Size  
Flavor   Imprint Code  
Contains  
Packaging
# NDC Package Description Multilevel Packaging
1 10812-130-90 1BOTTLEIn1KIT contains a BOTTLE, PUMP
1   10mLIn1BOTTLE, PUMP This package is contained within the KIT(10812-130-90)

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part352 04/15/2010  

Labeler -Neutrogena Corporation(008254617) 
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇OXY CLINICAL HYDRATING THERAPY(.. 下一篇DOVE CLINICAL PROTECTION COOL E..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位